Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-21.54	830.64	-1058.74
Graham Fair Price	-61.71	0.70	1.83
PEG	2529.53	2.09	-0.08
Price/Book	-3.71	1.15	1.20
Price/Cash Flow	79.57	-88.36	-432.44
Prices/Earnings	-554.66	-178.82	-27.31
Price/Sales	-21.64	32.84	41.91
Price/FCF	79.57	-88.36	-432.44
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	15.08	0.27	0.23
Operating Margin	69.91	-0.06	-0.19
ROA	84.83	< 0.005	< 0.005
ROE	-0.01	< 0.005	85.29
ROIC	< 0.005	< 0.005	84.39
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.07	< 0.005	-3292.93
Dividends QOQ	-0.04	-0.06	-74.06
EBIT QOQ	-0.41	0.63	52.27
EPS QOQ	-3.43	0.85	-75.10
FCF QOQ	-1.06	-3.70	-249.59
Revenue QOQ	< 0.005	0.23	4844.51
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.23	0.24	4.14
Days Sales Outstanding (DSO)	7.60	10.45	37.44
Inventory Turnover	396.93	381.16	-3.97
Debt/Capitalization	0.25	0.24	-5.13
Quick Ratio	9.05	10.43	15.16
Naive Interpretation	member

04 - Leverage & Liquidity · Balanced

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	3.68	3.67	-0.16
Cash	4.01	3.85	-4.01
Capex	< 0.005	< 0.005	-174.64
Free Cash Flow	-0.01	-0.05	-370.49
Revenue	0.10	0.13	22.68
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	2.07	2.12	2.03
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-125.42	110.72	-11.72
Naive Interpretation	Member

06 - Financial Health · Bad

Rating